Author:
O’Brien S.,Bhutiani N.,Egger M. E.,Brown A. N.,Weaver K. H.,Kline D.,Kelly L. R.,Scoggins C. R.,Martin R. C. G.,Vitale G. C.
Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. Saha SK, Zhu AX, Fuchs CS, Brooks GA (2016) Forty-year trends in cholangiocarcinoma incidence in the U.S.: intrahepatic disease on the rise. Oncologist 21(5):594–599
2. Eckmann KR, Patel DK, Landgraf A et al (2011) Chemotherapy outcomes for the treatment of unresectable intrahepatic and hilar cholangiocarcinoma: a retrospective analysis. Gastrointest Cancer Res 4(5–6):155–160
3. Ramirez-Merino N, Aix SP, Cortes-Funes H (2013) Chemotherapy for cholangiocarcinoma: an update. World J Gastrointest Oncol 5(7):171–176
4. Launois B, Reding R, Lebeau G, Buard JL (2000) Surgery for hilar cholangiocarcinoma: French experience in a collective survey of 552 extrahepatic bile duct cancers. J Hepato-biliary-pancreatic Surg 7(2):128–134
5. DeOliveira ML, Cunningham SC, Cameron JL et al (2007) Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg 245(5):755–762
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献